Tower Research Capital (TRC)’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $920 | Buy |
2,395
+377
| +19% | +$145 | ﹤0.01% | 4911 |
|
2025
Q1 | $2.34K | Sell |
2,018
-636
| -24% | -$738 | ﹤0.01% | 4562 |
|
2024
Q4 | $2.59K | Buy |
2,654
+595
| +29% | +$581 | ﹤0.01% | 4811 |
|
2024
Q3 | $3.03K | Sell |
2,059
-2,740
| -57% | -$4.03K | ﹤0.01% | 4904 |
|
2024
Q2 | $6.48K | Sell |
4,799
-113
| -2% | -$153 | ﹤0.01% | 4574 |
|
2024
Q1 | $8.06K | Buy |
4,912
+2,484
| +102% | +$4.07K | ﹤0.01% | 4089 |
|
2023
Q4 | $4.69K | Buy |
+2,428
| New | +$4.69K | ﹤0.01% | 4928 |
|
2023
Q1 | – | Sell |
-10,349
| Closed | -$28K | – | 6290 |
|
2022
Q4 | $28K | Buy |
10,349
+10,345
| +258,625% | +$28K | ﹤0.01% | 2820 |
|
2022
Q3 | $0 | Sell |
4
-1,690
| -100% | – | ﹤0.01% | 6507 |
|
2022
Q2 | $10K | Buy |
1,694
+1,560
| +1,164% | +$9.21K | ﹤0.01% | 4489 |
|
2022
Q1 | $2K | Sell |
134
-569
| -81% | -$8.49K | ﹤0.01% | 5607 |
|
2021
Q4 | $10K | Sell |
703
-924
| -57% | -$13.1K | ﹤0.01% | 4612 |
|
2021
Q3 | $48K | Buy |
1,627
+1,212
| +292% | +$35.8K | ﹤0.01% | 3003 |
|
2021
Q2 | $19K | Buy |
415
+29
| +8% | +$1.33K | ﹤0.01% | 3952 |
|
2021
Q1 | $23K | Sell |
386
-150
| -28% | -$8.94K | ﹤0.01% | 3784 |
|
2020
Q4 | $28K | Sell |
536
-2,984
| -85% | -$156K | ﹤0.01% | 3631 |
|
2020
Q3 | $121K | Buy |
3,520
+2,941
| +508% | +$101K | ﹤0.01% | 3000 |
|
2020
Q2 | $51K | Buy |
579
+459
| +383% | +$40.4K | ﹤0.01% | 3034 |
|
2020
Q1 | $7K | Sell |
120
-507
| -81% | -$29.6K | ﹤0.01% | 2195 |
|
2019
Q4 | $45K | Sell |
627
-114
| -15% | -$8.18K | ﹤0.01% | 1415 |
|
2019
Q3 | $45K | Buy |
+741
| New | +$45K | ﹤0.01% | 1872 |
|
2019
Q2 | – | Sell |
-655
| Closed | -$53K | – | 4313 |
|
2019
Q1 | $53K | Buy |
+655
| New | +$53K | ﹤0.01% | 1744 |
|
2018
Q4 | – | Sell |
-99
| Closed | -$16K | – | 4367 |
|
2018
Q3 | $16K | Buy |
+99
| New | +$16K | ﹤0.01% | 2491 |
|